Newsroom

Comparison of the Baseline Clinical and HRCT Characteristics of Insilico’s ISM001_055 Phase 2a Trial Cohort in China with Real-World IPF Datasets
18 November 2025

Comparison of the Baseline Clinical and HRCT Characteristics of Insilico’s ISM001_055 Phase 2a Trial Cohort in China with Real-World IPF Datasets

2025 ERS Abstract
PMG1015 Demonstrates a Well-Tolerated Safety Profile and Favorable FVC Changes after 12 Weeks of Treatment in IPF Patients
18 November 2025

PMG1015 Demonstrates a Well-Tolerated Safety Profile and Favorable FVC Changes after 12 Weeks of Treatment in IPF Patients

2025 ERS Abstract
Deep Learning-based Fibrosis and Ground Glass Opacification Quantification with Proteomic Biomarkers for Outcome Prediction in Idiopathic Pulmonary Fibrosis.
18 November 2025

Deep Learning-based Fibrosis and Ground Glass Opacification Quantification with Proteomic Biomarkers for Outcome Prediction in Idiopathic Pulmonary Fibrosis.

2025 ERS Abstract
Longitudinal Changes in Quantitative Imaging Biomarkers are Associated with Increased Risk of Mortality in Connective Tissue Disease-Related Interstitial Lung Disease
18 November 2025

Longitudinal Changes in Quantitative Imaging Biomarkers are Associated with Increased Risk of Mortality in Connective Tissue Disease-Related Interstitial Lung Disease

2025 ERS Abstract
Deep Learning-Based Airway and Vessel Volume are Associated with Increased Risk of Mortality in Connective Tissue Disease-Related Interstitial Lung Disease.
18 November 2025

Deep Learning-Based Airway and Vessel Volume are Associated with Increased Risk of Mortality in Connective Tissue Disease-Related Interstitial Lung Disease.

2025 ERS Abstract
Deep Learning-based Image Quantification of CTPA to Phenotype Pulmonary Arterial Hypertension
18 November 2025

Deep Learning-based Image Quantification of CTPA to Phenotype Pulmonary Arterial Hypertension

2025 ERS Abstract
Deep Learning Analysis of Serial CT Scans Correlates with Changes in how Patients Feel, Function and Survive in Fibrotic Interstitial Lung Disease
18 November 2025

Deep Learning Analysis of Serial CT Scans Correlates with Changes in how Patients Feel, Function and Survive in Fibrotic Interstitial Lung Disease

2025 ERS Abstract
The Role of Quantitative CT in the Prognostication and Monitoring of Systemic Autoimmune Rheumatic Disease Related Interstitial Lung Disease
2 November 2025

The Role of Quantitative CT in the Prognostication and Monitoring of Systemic Autoimmune Rheumatic Disease Related Interstitial Lung Disease

2025 BTS Abstract
Pulmonary Blood Volumes on CT Predict Residual Pulmonary Hypertension Post-Pulmonary Endarterectomy
21 October 2025

Pulmonary Blood Volumes on CT Predict Residual Pulmonary Hypertension Post-Pulmonary Endarterectomy

Combined Deep Learning Algorithms Demonstrate That Both Computed Tomography Phenotype and Anatomical Biomarkers Are Predictive of Prognosis and Progression in Idiopathic Pulmonary Fibrosis
17 October 2025

Combined Deep Learning Algorithms Demonstrate That Both Computed Tomography Phenotype and Anatomical Biomarkers Are Predictive of Prognosis and Progression in Idiopathic Pulmonary Fibrosis

ATS Journals
The Potential for Deep Learning Technology in Clinical Trials
12 June 2025

The Potential for Deep Learning Technology in Clinical Trials

Journal of Clinical Studies
Deep Learning Quantitative Computed Tomography Analysis in the Australian Idiopathic Pulmonary Fibrosis Registry
17 May 2025

Deep Learning Quantitative Computed Tomography Analysis in the Australian Idiopathic Pulmonary Fibrosis Registry

ATS Journals
Deep Learning-based Disease Severity Biomarkers on CT; Posthoc Analysis in a Phase 2a Placebo-controlled Study of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis
16 May 2025

Deep Learning-based Disease Severity Biomarkers on CT; Posthoc Analysis in a Phase 2a Placebo-controlled Study of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis

ATS Journals
Monte Carlo External Control Arm Generation Utilising Real-world Patient Data and Deep Learning-based Quantitative CT Metrics Demonstrates Treatment Effect in the Atlas IPF Trial
16 May 2025

Monte Carlo External Control Arm Generation Utilising Real-world Patient Data and Deep Learning-based Quantitative CT Metrics Demonstrates Treatment Effect in the Atlas IPF Trial

ATS Journals
Deep Learning-Based Short-Term Disease Progression Evaluation Supersedes Automated Baseline CT Phenotype in Predicting Outcomes in Idiopathic Pulmonary Fibrosis
16 May 2025

Deep Learning-Based Short-Term Disease Progression Evaluation Supersedes Automated Baseline CT Phenotype in Predicting Outcomes in Idiopathic Pulmonary Fibrosis

ATS Journals
Deep Learning-Based Quantitative CT and CT Phenotype Classification Independently Predict Mortality in Idiopathic Pulmonary Fibrosis, a Prospective Observational Cohort Study
16 May 2025

Deep Learning-Based Quantitative CT and CT Phenotype Classification Independently Predict Mortality in Idiopathic Pulmonary Fibrosis, a Prospective Observational Cohort Study

ATS Journals
Deep Learning-based Quantitative CT and Proteomics for Predicting Outcomes in Idiopathic Pulmonary Fibrosis
16 May 2025

Deep Learning-based Quantitative CT and Proteomics for Predicting Outcomes in Idiopathic Pulmonary Fibrosis

ATS Journals
Dose-Dependent Change of Inhaled Pirfenidone Seen in Lung Volume and Fibrosis Quantification in Patients With IPF: A Deep Learning Image-Based Analysis of Data From the ATLAS Phase 1b Trial
16 May 2025

Dose-Dependent Change of Inhaled Pirfenidone Seen in Lung Volume and Fibrosis Quantification in Patients With IPF: A Deep Learning Image-Based Analysis of Data From the ATLAS Phase 1b Trial

ATS Journals